Outcome of spontaneous intracerebral hematoma associated with baseline troponin T-HS

Troponin T-HS I is a widely used and reliable marker of myocardial damage. It is studied in ischemic stroke and subarachnoid hemorrhage as independent prognostic factor for mortality. However, the significance of troponin T-HS elevation in spontaneous intracranial hemorrhage (sICH) is not well studied. A retrospective medical record review from 01.01.2019 – 31.12.2019 was performed in the Pauls Stradins Clinical University Hospital and in Riga East Clinical University Hospital Gailezers. Together we collected 200 records. A total of 200 patients were included, of whom 49% (n = 98) were women and 51% (n = 102) were men. Of these, 68% (n = 136) patients were alive at discharge (mean 6.81 days ± 5 days) and 32% (n = 64) were dead. In the living group, the mean troponin T-HS was 27.46 ± 61.54 ng / L, minimum 3 ng / L, maximum 521 ng / L. In the group of dead, troponin averaged 62.18 ± 112.7 ng / L, minimum 3 ng / L, maximum 464 ng / L (p = 0.002). If a patient has an elevated blood level of troponin T-HS at the time of onset, the higher the risk of the patient dying during hospitalization.